Pharmacy Corporation of America v. Askari
Plaintiff: Pharmacy Corporation of America
Defendant: Kaveh Askari
Case Number: 1:2016cv01123
Filed: December 5, 2016
Court: US District Court for the District of Delaware
Office: Wilmington Office
County: New Castle
Presiding Judge: Richard G. Andrews
Nature of Suit: Other Contract
Cause of Action: 28 U.S.C. ยง 1332
Jury Demanded By: None

Available Case Documents

The following documents for this case are available for you to view or download:

Date Filed Document Text
September 3, 2021 Opinion or Order Filing 234 MEMORANDUM OPINION. Signed by Judge Richard G. Andrews on 9/3/2021. (lak)
September 8, 2020 Opinion or Order Filing 224 TRIAL OPINION: Plaintiffs have failed to meet their burden of showing that Defendant breached the Operating Agreement at either the First or Second Call. Plaintiffs have also failed to meet their burden of showing that Defendant breached the implie d covenant of good faith and fair dealing. Defendant has failed to meet its burden of showing that Askari has breached the restrictive covenant in § 7.2(a) of the MIPA. The parties are directed to jointly submit an agreed-upon form of final judgment within one week. Signed by Judge Richard G. Andrews on 9/8/2020. (nms)
June 9, 2020 Opinion or Order Filing 211 MEMORANDUM ORDER: Plaintiffs' motion for reargument (D.I. 197 ) and request to amend the pleadings are DENIED. Signed by Judge Richard G. Andrews on 6/9/2020. (nms)
April 23, 2020 Opinion or Order Filing 196 MEMORANDUM ORDER regarding motions in limine (see Memorandum for further details). Signed by Judge Richard G. Andrews on 4/23/2020. (nms)
August 9, 2018 Opinion or Order Filing 86 MEMORANDUM ORDER: Defendants' Objections 77 are OVERRULED. The Report and Recommendation 76 is ADOPTED. Defendants' Motion to Dismiss 55 is DENIED (see Order for further details). Signed by Judge Richard G. Andrews on 8/8/2018. (ksr, )
May 7, 2018 Opinion or Order Filing 76 REPORT AND RECOMMENDATIONS re 55 MOTION to Dismiss filed by Pharmacy Corporation of America. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than t en (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 5/21/2018. Signed by Judge Mary Pat Thynge on 5/7/18. (cak)
Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Pharmacy Corporation of America v. Askari
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Pharmacy Corporation of America
Represented By: Brett D. Fallon
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Kaveh Askari
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?